BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34995415)

  • 1. Off-target inhibition of NGLY1 by the polycaspase inhibitor Z-VAD-fmk induces cellular autophagy.
    Needs SH; Bootman MD; Grotzke JE; Kramer HB; Allman SA
    FEBS J; 2022 Jun; 289(11):3115-3131. PubMed ID: 34995415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytoplasmic peptide:N-glycanase (NGLY1) - Structure, expression and cellular functions.
    Suzuki T; Huang C; Fujihira H
    Gene; 2016 Feb; 577(1):1-7. PubMed ID: 26611529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of the Structure and Function of Peptide:N-Glycanase 1 and Relationship with Congenital Disorder of Deglycosylation.
    Miao X; Wu J; Chen H; Lu G
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological importance of NGLY1, as revealed by rodent model analyses.
    Fujihira H; Asahina M; Suzuki T
    J Biochem; 2022 Feb; 171(2):161-167. PubMed ID: 34580715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity.
    Tambe MA; Ng BG; Freeze HH
    Cell Rep; 2019 Dec; 29(13):4620-4631.e4. PubMed ID: 31875565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endo-β-N-acetylglucosaminidase forms N-GlcNAc protein aggregates during ER-associated degradation in Ngly1-defective cells.
    Huang C; Harada Y; Hosomi A; Masahara-Negishi Y; Seino J; Fujihira H; Funakoshi Y; Suzuki T; Dohmae N; Suzuki T
    Proc Natl Acad Sci U S A; 2015 Feb; 112(5):1398-403. PubMed ID: 25605922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. z-VAD-fmk inhibits peptide:N-glycanase and may result in ER stress.
    Misaghi S; Korbel GA; Kessler B; Spooner E; Ploegh HL
    Cell Death Differ; 2006 Jan; 13(1):163-5. PubMed ID: 16003388
    [No Abstract]   [Full Text] [Related]  

  • 8. The cytoplasmic peptide:N-glycanase (Ngly1)-basic science encounters a human genetic disorder.
    Suzuki T
    J Biochem; 2015 Jan; 157(1):23-34. PubMed ID: 25398991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomics reveals elevated CCN2 in NGLY1-deficient cells.
    Hetz R; Magaway C; Everett J; Li L; Willard BB; Freeze HH; He P
    Biochem Biophys Res Commun; 2022 Dec; 632():165-172. PubMed ID: 36209585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of N-Glycanase 1 Alters Transcriptional and Translational Regulation in K562 Cell Lines.
    Mueller WF; Jakob P; Sun H; Clauder-Münster S; Ghidelli-Disse S; Ordonez D; Boesche M; Bantscheff M; Collier P; Haase B; Benes V; Paulsen M; Sehr P; Lewis J; Drewes G; Steinmetz LM
    G3 (Bethesda); 2020 May; 10(5):1585-1597. PubMed ID: 32265286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches.
    Owings KG; Lowry JB; Bi Y; Might M; Chow CY
    Hum Mol Genet; 2018 Mar; 27(6):1055-1066. PubMed ID: 29346549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ever-expanding NGLY1 biology.
    Suzuki T; Yoshida Y
    J Biochem; 2022 Feb; 171(2):141-143. PubMed ID: 34969094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a fluorescence and quencher-based FRET assay for detection of endogenous peptide:N-glycanase/NGLY1 activity.
    Hirayama H; Tachida Y; Fujinawa R; Matsuda Y; Murase T; Nishiuchi Y; Suzuki T
    J Biol Chem; 2024 Apr; 300(4):107121. PubMed ID: 38417795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for assaying peptide: N-glycanase/N-glycanase 1 activities in crude extracts using an N-glycosylated cyclopeptide.
    Hirayama H; Tachida Y; Seino J; Suzuki T
    Glycobiology; 2022 Mar; 32(2):110-122. PubMed ID: 34939090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver-specific deletion of Ngly1 causes abnormal nuclear morphology and lipid metabolism under food stress.
    Fujihira H; Masahara-Negishi Y; Akimoto Y; Hirayama H; Lee HC; Story BA; Mueller WF; Jakob P; Clauder-Münster S; Steinmetz LM; Radhakrishnan SK; Kawakami H; Kamada Y; Miyoshi E; Yokomizo T; Suzuki T
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165588. PubMed ID: 31733337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Natural Compound Containing a Disaccharide Structure of Glucose and Rhamnose Identified as Potential N-Glycanase 1 (NGLY1) Inhibitors.
    Liu R; Gu J; Ye Y; Zhang Y; Zhang S; Lin Q; Yuan S; Chen Y; Lu X; Tong Y; Lv S; Chen L; Sun G
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of N-glycanase 1 perturbs neurogenesis and cerebral development modeled by human organoids.
    Lin VJT; Hu J; Zolekar A; Salick MR; Mittal P; Bird JT; Hoffmann P; Kaykas A; Byrum SD; Wang YC
    Cell Death Dis; 2022 Mar; 13(3):262. PubMed ID: 35322011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular autophagy, an unbidden effect of caspase inhibition by zVAD-fmk.
    Sakthivel D; Bolívar BE; Bouchier-Hayes L
    FEBS J; 2022 Jun; 289(11):3097-3100. PubMed ID: 35043564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New perspectives on the mutated NGLY1 enigma.
    Tickotsky-Moskovitz N
    Med Hypotheses; 2015 Nov; 85(5):584-5. PubMed ID: 26228302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescently labeled inhibitor for profiling cytoplasmic peptide:N-glycanase.
    Hagihara S; Miyazaki A; Matsuo I; Tatami A; Suzuki T; Ito Y
    Glycobiology; 2007 Oct; 17(10):1070-6. PubMed ID: 17640972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.